Skip to content

Healthpeak Properties DOC Redeemable noncontrolling interests in subsidiaries

Redeemable noncontrolling interests in subsidiaries at other companies

Equity Residential logo
Equity ResidentialEQR
Tenet Healthcare logo
Tenet HealthcareTHC
Encompass Health Corporation logo
Encompass Health CorporationEHC
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$753.0M+7.1%
Gross profit$414.0M-1.5%
Net income$193.6M+352%
EPS (diluted)$0.28+367%

Balance sheet

See full
Cash & equivalents$1.2B+1,558%
Total debt$290.1M-5.4%
Total equity$7.8B-4.4%
Total assets$21.6B+9.1%

Cash flow

See full
Operating cash flow$260.9M-6.6%

Valuation

See full
Market cap$13.49B-19.1%
Enterprise value$12.6B-26.6%
P/E60.7×+1.0×
P/S4.7×-1.3×

Profitability

See full
Gross margin60.1%+0.1pp
Net margin7.7%-2.3pp

Returns & leverage

See full
Return on equity2.8%-0.5pp
Debt / equity0.0×

Where this comes from

Reported directly by Healthpeak Properties in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.

The official record: Healthpeak Properties’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Healthpeak Properties's redeemable noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Healthpeak Properties's redeemable noncontrolling interests in subsidiaries?
Healthpeak Properties (DOC) reported redeemable noncontrolling interests in subsidiaries of $27.21M in Q1 2026.
How has Healthpeak Properties's redeemable noncontrolling interests in subsidiaries changed year-over-year?
Healthpeak Properties's redeemable noncontrolling interests in subsidiaries increased by 88.8% year-over-year, from $14.42M to $27.21M.
What is the long-term trend for Healthpeak Properties's redeemable noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Healthpeak Properties's redeemable noncontrolling interests in subsidiaries has grown at a 22.7% compound annual growth rate (CAGR), from $57.4M to $159.58M.